According to the Endocrine Society, an estimated 5 to 6 million women in America are affected with polycystic ovary syndrome (PCOS), a condition marked by elevated testosterone, ovulation problems and large ovaries with small follicles.1 Around the world, 8% to 13% of women have PCOS, and many more remain undiagnosed.2 I believe PCOS is an… Read More: Polycystic Ovarian Syndrome — A Health Issue Affecting Women Worldwide »
Carrie Ann Inaba is a familiar face in millions of American homes. A lifelong dancer, she has become well-known as a judge on ABC’s competition show “Dancing with the Stars.” Last year, she became co-host of the CBS daytime talk show “The Talk.” Outside of her on-camera career, Inaba is a self-described warrior for those with… Read More: Carrie Ann Inaba Doesn’t Let Sjögren’s Syndrome Stand In Her… »
Metabolic syndrome may be the most common and serious condition you’ve never heard of. (At least that’s what I found out when I asked friends and relatives about it.) Worse, a study published recently in JAMA shows that it’s on the rise. Let’s start with the name, according to Merriam-Webster: Metabolic: Relating to the chemical… Read More: Metabolic syndrome is on the rise: What it is and… »
Print this page FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ — Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela is a minimally-absorbed small molecule that acts locally in the… Read More: FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel… »